IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Accentia Biopharmaceuticals

CUSIP: 00430L103 | 5 institutional holders

Quarters

Q2 2017Q1 2017Q4 2016Q3 2016Q2 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2017

Blair William & Co17,500
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Blair William & Co
17,500$00.0%MomentumLowChicago, IL2017-08-04